Objective:
Ensure affordable access to Clomid and other fertility-related medications for men as part of comprehensive hormonal health care.
Rationale:
- Many men with low testosterone struggle to access treatment due to high costs or lack of insurance coverage.
- Including these medications in Medicaid and insurance formularies would reduce reliance on synthetic testosterone, which can have significant side effects.
Action Plan:
- Propose state and federal legislation requiring public and private insurers to cover FDA-approved testosterone boosters like Clomid for low-T treatment.
- Highlight the cost savings of natural testosterone boosters compared to long-term synthetic testosterone therapy.